You are here

Chris Froome anti-doping investigation should not have been made public, says British Cycling boss

This article is originally from Cycling Week

Julia Harrington says case has harmed reputations before it’s been established whether Froome has done anything wrong

Chris Froome places third in the elite men’s time trial at the 2017 UCI Road World Championships. Photo: Yuzuru Sunada Credit: Yuzuru Sunada

British Cycling chief executive Julia Harrington has criticised the leaking of Chris Froome’s adverse analytical finding for high levels of salbutamol, saying that the case has harmed the reputations of Froome, British Cycling, and cycling as a sport.

Speaking at British Cycling headquarters in Manchester, Harrington said that she was disappointed that news of the anti-doping investigation into Froome had become public knowledge, and that reputations had been tarnished before it had been decided whether Froome had broken any rules.

“The issue in this case is that the process was leaked and while somebody is trying to prove either way why they had that adverse analytical finding it’s being debated in the court of public opinion,” Harrington told The Guardian.

“That’s a blow to cycling’s reputation, the individual athlete’s reputation. You only need to look at Twitter feeds and the comments below articles and people will make up their own mind based on not having the full evidence, which is a shame.”

>>> Chris Froome is back on Strava and the rides he’s been uploading are incredible

Froome denies exceeding the permitted dosage for salbutamol of 800mg per 12 hours, and must prove that the high concentration of the asthma drug found in his urine after

Continue reading this article originally posted on Cycling Week >>>

Leave a Reply